Solana Company (HSDT)
HSDT Stock Price Chart
Explore Solana Company interactive price chart. Choose custom timeframes to analyze HSDT price movements and trends.
HSDT Company Profile
Discover essential business fundamentals and corporate details for Solana Company (HSDT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
27 Jun 2014
Employees
21.00
Website
https://solana.comCEO
Dane Carl Andreeff
Description
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
HSDT Financial Timeline
Browse a chronological timeline of Solana Company corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.02, while revenue estimate is $3.50m.
Earnings released on 15 May 2026
EPS came in at -$1.30 falling short of the estimated -$0.12 by -983.33%, while revenue for the quarter reached $3.62m , beating expectations by +6.50%.
Earnings released on 30 Mar 2026
EPS came in at $4.25 surpassing the estimated -$26.50 by +116.04%, while revenue for the quarter reached $5.23m , beating expectations by +3.63k%.
Earnings released on 18 Nov 2025
EPS came in at -$32.89 surpassing the estimated -$50.50 by +34.87%, while revenue for the quarter reached $697.00k , beating expectations by +533.64%.
Earnings released on 14 Aug 2025
EPS came in at -$79.73 surpassing the estimated -$128.50 by +37.95%, while revenue for the quarter reached $43.00k , missing expectations by -60.91%.
Stock split effective on 1 Jul 2025
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 2 May 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 May 2025
EPS came in at -$382.31 falling short of the estimated -$8.70 by -4.29k%, while revenue for the quarter reached $49.00k , missing expectations by -55.45%.
Earnings released on 25 Mar 2025
EPS came in at -$1.03 falling short of the estimated -$0.94 by -9.57%, while revenue for the quarter reached $152.00k , beating expectations by +52.00%.
Earnings released on 12 Nov 2024
EPS came in at -$0.99 surpassing the estimated -$1.06 by +6.60%, while revenue for the quarter reached $51.00k , missing expectations by -49.00%.
Earnings released on 12 Aug 2024
EPS came in at -$0.64 falling short of the estimated -$0.50 by -28.00%, while revenue for the quarter reached $182.00k , beating expectations by +21.33%.
Earnings released on 13 May 2024
EPS came in at -$3.08 surpassing the estimated -$3.87 by +20.41%, while revenue for the quarter reached $135.00k , beating expectations by +3.85%.
Earnings released on 28 Mar 2024
EPS came in at -$1.47 surpassing the estimated -$4.05 by +63.70%, while revenue for the quarter reached $134.00k , missing expectations by -46.40%.
Earnings released on 9 Nov 2023
EPS came in at -$5.49 surpassing the estimated -$6.00 by +8.50%, while revenue for the quarter reached $143.00k , missing expectations by -48.93%.
Stock split effective on 17 Aug 2023
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Aug 2023
EPS came in at -$3.00 surpassing the estimated -$5.50 by +45.45%, while revenue for the quarter reached $256.00k , missing expectations by -20.00%.
Earnings released on 11 May 2023
EPS came in at -$4.50 surpassing the estimated -$5.00 by +10.00%, while revenue for the quarter reached $111.00k , missing expectations by -72.25%.
Earnings released on 9 Mar 2023
EPS came in at -$8.50 falling short of the estimated -$5.50 by -54.55%, while revenue for the quarter reached $282.00k , beating expectations by +8.46%.
Earnings released on 14 Nov 2022
EPS came in at -$6.00 surpassing the estimated -$12.00 by +50.00%, while revenue for the quarter reached $196.00k , beating expectations by +17.01%.
Earnings released on 15 Aug 2022
EPS came in at -$48.50 falling short of the estimated -$1.12 by -4.23k%, while revenue for the quarter reached $119.00k , missing expectations by -66.94%.
Earnings released on 12 May 2022
EPS came in at -$57.50 falling short of the estimated -$1.13 by -4.99k%, while revenue for the quarter reached $190.00k , beating expectations by +18.75%.
Earnings released on 14 Mar 2022
EPS came in at -$65.50 falling short of the estimated -$1.16 by -5.55k%, while revenue for the quarter reached $258.00k , beating expectations by +158.00%.
Earnings released on 10 Nov 2021
EPS came in at -$100.50 falling short of the estimated -$87.50 by -14.86%, while revenue for the quarter reached $109.00k , beating expectations by +17.45%.
Earnings released on 12 Aug 2021
EPS came in at -$129.00 falling short of the estimated -$76.50 by -68.63%, while revenue for the quarter reached $71.00k , beating expectations by +28.79%.
HSDT Stock Performance
Access detailed HSDT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
